Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria
|
|
- Jacob Matthews
- 6 years ago
- Views:
Transcription
1 Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer : a validation study of the GOG criteria Suk-Joon Chang, MD, Hee-Sug Ryu MD Gynecologic Cancer Center Department of Obstetrics and Gynecology Ajou University School of Medicine Suwon, Korea
2 Disclosure No relevant conflict of interests to disclose
3 Adjuvant treatment in patients with endometrial cancer Surgically staged endometrial cancer patients can be classified into three categories. - Low risk - Intermediate risk - High risk Adjuvant treatment is given to patients with intermediate- to high-risk tumors. - Radiotherapy - Chemotherapy (Morrow et al, 1991; Fanning, 2001; Odagiri et al, 2011; Kong et al, 2013)
4 Criteria for risk group Criteria for risk group : comparison of clinical trial inclusion criteria of PORTEC-1,2 and GOG 99. Low risk FIGO stage IA Intermediate risk FIGO stage IB, stage IC, stage II High-intermediate risk GOG 99 PORTEC-1,2 Any age and : Age > 60 years and (1) G2-3 (1) Stage IC G1/2 (2) LVSI (+) (2) Stage IB G3 (3) Outer third invasion Any age, stage IIA Age years, with 2 of 3 of the above listed factors Age 70 years, with 1 of 3 of the above listed factors High risk FIGO stage III, stage IV Serous or clear cell histology (Creutzberg et al, 2000; Fanning, 2001; Keys et al, 2004; Nout et al, 2010)
5 Some considerations The FIGO staging system was revised in 2009 and the current criteria based on the 1988 FIGO staging system did not fit in well with the updated staging system. High-intermediate risk criteria of GOG 99 seem to be so complicated and those of PORTEC seem to be incomplete because of lacking LVSI and LN status.
6 Objective The purpose of this study is to validate the previous risk criteria of GOG 99 for adjuvant treatment and to evaluate the novel risk criteria predicting the prognosis and tailoring adjuvant treatment in patients with endometrial cancer who underwent complete surgical staging procedures.
7 Methods Retrospective study ~ consecutive patients with surgically staged endometrial cancer - Total hysterectomy, adnexectomy, peritoneal washings for cytology - Lymphadenectomy: pelvic and para-aortic New risk criteria for adjuvant treatment - FIGO stage (2009 system) - Grade - LVSI Statistical analysis : Kaplan-Meyer method, ROC curve
8 Results (1) Patients characteristics Characteristics N (%) or median (range) Characteristics N (%) or median (range) Median age, year 51 (29-81) Tumor grade Median parity 2 (0-6) (67.8) FIGO stage 2 40 (15.3) IA 171 (65.5) 3 42 (16.1) IB 28 (10.7) N/A 2 (0.8) II 22 (8.4) Myometrial invasion IIIA 3 (1.1) < 1/2 involvement 192 (73.6) IIIB 2 (0.8) 1/2 involvement 69 (26.4) IIIC1 12 (4.6) LVSI IIIC2 16(6.1) Absent 197 (75.5) IVB 7 (2.7) Present 64 (24.5) Histology Adjuvant treatment Endometrioid 229 (87.7) No 178 (68.2) Serous papillary 13 (5.0) Yes 83 (31.8) Mixed 19 (7.3) FU, months 48 (10-122)
9 Results (2) Univariate and multivariate analyses Variable N(%) Univariate P value Multivariate OR (95% CI) P value Age (continuous) ( ) 0.91 Grade < ( ) 0.01 LVSI Absent Present 64 < ( ) <0.01 9
10 Results (3) Comparison of patients group GOG criteria (based on 1988 FIGO staging system) New Criteria (based on 2009 FIGO staging system) Low risk 78 (Stage IA) 170 (Stage IA) Intermediate risk 139 (Stage IB, IC, IIA, IIB) 46 (Stage IB, II) High-intermediate risk* High risk 44 (Stage III, IV) 45 (Stage III, IV) * Risk factors 1) Grade 2 or 3 histology 2) Positive LVSI 3) Myometrial invasion to outer 1/3 1) Grade 2 or 3 histology 2) Positive LVSI Any age + 3 factors Age factors Age factor Any age + 1 factor 10
11 Results (4) Survival analysis Low risk High-Intermediate risk Low risk High-Intermediate risk High risk High risk A A Low risk High-Intermediate risk Low risk High-Intermediate risk High risk High risk B DFS (A) and OS (B) by GOG criteria (P < 0.01) DFS (A) and OS (B) by New criteria (P < 0.01) B 11
12 Results (5) Comparison of performances AUC (95% CI) SE P value GOG criteria ( ) < 0.01 New Criteria ( ) < 0.01 Pairwise comparison of ROC curves Difference between areas = SE = (95% CI, to 0.061) P = AUC (95% CI) SE P value GOG criteria ( ) < 0.01 New Criteria ( ) < 0.01 Pairwise comparison of ROC curves Difference between areas = SE = (95% CI, to 0.057) P =
13 Conlusions The current study suggests the possibility that the simplified new criteria could be established, which predict prognosis and select proper candidates for adjuvant treatment in surgically staged endometrial cancer patients. Our new criteria may be easily applicable and offer useful information for planning strategy of adjuvant treatment in patients with endometrial cancer as the GOG criteria.
Endometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines
Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Endometrial Cancer Emad R. Sagr, MBBS, FRCSC Consultant Gynecology Oncology Security forces Hospital, Riyadh Epidemiology
More informationAdjuvant Therapies in Endometrial Cancer. Emma Hudson
Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial
More informationsurgical staging g in early endometrial cancer
Risk adapted d approach to surgical staging g in early endometrial cancer Leon Massuger University Medical Centre St Radboud Nijmegen, The Netherlands Doing nodes Yes Yes Yes No No No 1957---------------------------
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationStaging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion
5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year
More informationENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media
For mass reproduction, content licensing and permissions contact Dowden Health Media. UPDATE ENDOMETRIAL CANCER Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial
More informationShould the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
ORIGINAL STUDY Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade? Chunyan Lan, MD,* Xin Huang, MD,* Qidan
More informationENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre)
ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) Source: UpToDate 2017, ASCO/CCO/Alberta provincial guidelines, NCCN Reviewed by: Dr. Sarah Glaze (Gynecologic
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationTae-Wook Kong 1,2, Joo-Hyuk Son 1,2, Jiheum Paek 1,2, Yonghee Lee 1,3, Eun Ju Lee 1,4, Suk-Joon Chang 1,2, Hee-Sug Ryu 1,2
Preoperative nomogram for individualized prediction of parametrial invasion in patients with FIGO stage IB cervical cancer treated with radical hysterectomy Tae-Wook Kong 1,2, Joo-Hyuk Son 1,2, Jiheum
More informationRelapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3861 Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women RESEARCH ARTICLE Relapse Patterns and Outcomes Following
More informationRochester Minnesota Mayo Clinic
Are There Still Indications for Lymphadenectomy in Endometrial Cancer? A Mariani Mayo Clinic Rochester - MN USA Rochester Minnesota Mayo Clinic 1 Endometrial Cancer Lymphadenectomy Yes or No? Endometrial
More informationAnnual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
bs_bs_banner doi:10.1111/jog.12596 J. Obstet. Gynaecol. Res. Vol. 41, No. 2: 167 177, February 2015 Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationAnnual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013
bs_bs_banner doi:10.1111/jog.12360 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 338 348, February 2014 Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013 Daisuke
More informationNew Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%
Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%
More information17 th ESO-ESMO Masterclass in clinical Oncology
17 th ESO-ESMO Masterclass in clinical Oncology Cervical and endometrial Cancer Cristiana Sessa IOSI Bellinzona, Switzerland Berlin, March 28 th, 2018 Presenter Disclosures None Cervical Cancer Estimated
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer
THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT
More informationRadiation Therapy in Early Endometrial Cancers: Con
Radiation Therapy in Early Endometrial Cancers: Con 106 Jamie N. Bakkum-Gamez, MD Andrea Mariani, MD Karl C. Podratz, MD, PhD Introduction Endometrial cancer (EC) represents a heterogeneous spectrum of
More informationARRO Case: Early-stage Endometrial Cancer
ARRO Case: Early-stage Endometrial Cancer Ankit Modh, MD (PGY-4) Faculty Advisor: Mohamed A Elshaikh, MD Department of Radiation Oncology Henry Ford Cancer Institute Case Presentation 70 y/o African American
More informationAdjuvant Radiotherapy in Endometrial Carcinoma David T. Shaeffer and Marcus E. Randall. doi: /theoncologist
Adjuvant Radiotherapy in Endometrial Carcinoma David T. Shaeffer and Marcus E. Randall The Oncologist 2005, 10:623-631. doi: 10.1634/theoncologist.10-8-623 The online version of this article, along with
More informationExternal radiotherapy increases the risk of death from early stage endometrial cancer
External radiotherapy increases the risk of death from early stage endometrial cancer PM Tebeu 1,5, GY Popowski 2, HM Verkooijen 3, F Ludicke 4, M Usel 3, C Bouchardy 3, AL Major 1,4 Departments of 1 Obstetrics
More informationAdjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: A multi-institutional analysis of 608 women
Gynecologic Oncology 103 (2006) 661 666 www.elsevier.com/locate/ygyno Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: A multi-institutional analysis of 608 women O. Kenneth
More informationLymphovascular space invasion in early-stage endometrial cancer: adjuvant treatment and patterns of recurrence
Southern 10 African African Journal Journal of Gynaecological of Gynaecological Oncology Oncology 2016; 8(1):10-15 2016; 1(1):1 6 http://dx.doi.org/10.1080/20742835.2016.1175708 Open Access article article
More informationThe Role of Radiation in the Management of Gynecologic Cancers. Scott Glaser, MD
The Role of Radiation in the Management of Gynecologic Cancers Scott Glaser, MD Nothing to disclose DISCLOSURE Outline The role of radiation in: Endometrial Cancer Adjuvant Medically inoperable Cervical
More information3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates
J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs
More informationC ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)
CLINICAL C ORPUS UTERI C ARCINOMA STAGING FORM PATHOLOGIC Extent of disease before S TAGE C ATEGORY D EFINITIONS Extent of disease through any treatment completion of definitive surgery y clinical staging
More informationUTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS
Review Journal of Translational Medicine and Research, volume 19, no. 1-2, 2014 UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS N. Bacalbaæa 1, A. Traistaru 2, I. Bãlescu 3 1 Carol Davila University of Medicine
More informationARROCase: Locally Advanced Endometrial Cancer
ARROCase: Locally Advanced Endometrial Cancer Charles Vu, MD (PGY-3) Faculty Advisor: Peter Y. Chen, MD, FACR Beaumont Health (Royal Oak, MI) November 2016 Case 62yo female with a 3yr history of vaginal
More informationPrognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer
Prognostic significance of stroma tumorinfiltrating lymphocytes according to molecular subtypes of breast cancer Hee Jung Kwon, Nuri Jang, Min Hui Park, Young Kyung Bae Department of Pathology, Yeungnam
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationStage 3 ovarian cancer survival rate
Search Stage 3 ovarian cancer survival rate 19-5-2017 If you've been diagnosed with ovarian cancer, it's natural to wonder about your prognosis. Learn about survival rates, outlook, and more. Take the
More informationAdjuvant treatment, tumour recurrence and the survival rate of uterine serous carcinomas: a single-institution review of 62 women
Adjuvant treatment, tumour recurrence and the survival rate of uterine serous carcinomas: a single-institution review of 62 women Pol F, MD, Department of Obstetrics and Gynaecology, Radboud University
More informationClinical statistics of gynecologic cancers in Japan
J Gynecol Oncol. 2017 Mar;28(2):e32 pissn 2005-0380 eissn 2005-0399 Review Article Clinical statistics of gynecologic cancers in Japan Wataru Yamagami, 1,7 Satoru Nagase, 2,7 Fumiaki Takahashi, 3 Kazuhiko
More informationCarcinoma of the Fallopian Tube
119 Carcinoma of the Fallopian Tube APM HEINTZ, F ODICINO, P MAISONNEUVE, U BELLER, JL BENEDET, WT CREASMAN, HYS NGAN and S PECORELLI STAGING Anatomy Primary site The Fallopian tube extends from the posterior
More informationStage 3 ovarian cancer survival rate
Stage 3 ovarian cancer survival rate Gogamz Menu The latest ovarian cancer survival statistics for the UK for Health Professionals. See data for age, trends over time, stage at diagnosis and more. 5-8-2014
More informationWinship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer
Winship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer Ira R. Horowitz, MD, SM, FACOG, FACS John D. Thompson Professor and Chairman Department of Gynecology
More informationShina Oranratanaphan, Tarinee Manchana*, Nakarin Sirisabya
Comparison of Synchronous Endometrial and Ovarian Cancers versus Primary with Metastasis RESEARCH COMMUNICATION Clinicopathologic Variables and Survival Comparison of Patients with Synchronous Endometrial
More informationSignificance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma
ORIGINAL STUDY Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma Jeong-Yeol Park, MD, PhD, Dae-Yeon Kim, MD, PhD, Dae-Shik Suh, MD, PhD, Jong-Hyeok Kim, MD, PhD, Yong-Man
More informationManagement of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D.
Management of high risk early cervical cancer - a view of surgeon Dan DY Kim, M.D., Ph.D. Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
More informationThe new FIGO classification in endometrial carcinoma
The new FIGO classification in endometrial carcinoma Poster No.: C-1073 Congress: ECR 2012 Type: Educational Exhibit Authors: A. IGLESIAS CASTAÑON, M. Arias Gonzales, J. Mañas Uxó, 1 2 1 2 2 2 B. NIETO
More informationSCBT.MR MRI of Uterine Malignancy. Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC
2 0 1 6 SCBT.MR MRI of Uterine Malignancy Susan M. Ascher, MD, FSCBT.MR Georgetown University School of Medicine Washington, DC aschers@gunet.georgetown.edu MUST READS Sala E, et al. The added role of
More informationPrognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic lymph node metastases
Original Article J Gynecol Oncol Vol. 24, No. 3:229-235 pissn 2005-0380 eissn 2005-0399 Prognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix
THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April
More informationRole of Surgery in Cervical Cancer & Research Questions
Role of Surgery in Cervical Cancer & Research Questions Arb-aroon Lertkhachonsuk, M.D., Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Role of surgery in cervical cancer
More informationCharacteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution review of 51 cases
Arch Gynecol Obstet (2011) 283:1133 1137 DOI 10.1007/s00404-010-1574-2 GYNECOLOGIC ONNCOLOGY Characteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution
More informationImprovements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture
Original Article J Gynecol Oncol Vol. 24, No. 4:352-358 pissn 2005-0380 eissn 2005-0399 Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor
More informationIs Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
e-issn 1643-3750 DOI: 10.12659/MSM.897291 Received: 2015.12.27 Accepted: 2016.01.13 Published: 2016.02.08 Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix? Authors Contribution:
More informationHitting the High Points Gynecologic Oncology Review
Hitting the High Points is designed to cover exam-based material, from preinvasive neoplasms of the female genital tract to the presentation, diagnosis and treatment, including surgery, chemotherapy, and
More informationGynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0)
Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0) ** VALID ON DATE OF PRINTING ONLY all guidelines available on the Strategic Clinical Network website : GMLSC SCN Date first published
More informationBaseline risk of recurrence in stage I II endometrial carcinoma
J Gynecol Oncol. 2018 Jan;29(1):e9 pissn 2005-0380 eissn 2005-0399 Original Article Baseline risk of recurrence in stage I II endometrial carcinoma Shinsuke Sasada, 1,2 Mayu Yunokawa, 1,3 Yae Takehara,
More informationImpact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma
Hou et al. / Cancer Cell Research 3 (2014) 65-69 Cancer Cell Research Available at http:// http://www.cancercellresearch.org/ ISSN 2161-2609 Impact of Surgery Extent on Survival and Recurrence Rate of
More information29 Cancer of the Uterine Corpus
29 Cancer of the Uterine Corpus Robbert Soeters INTRODUCTION Malignancies affecting the uterine corpus are endometrial adenocarcinoma and uterine sarcomas. ENDOMETRIAL ADENOCARCINOMA Endometrial adenocarcinoma
More informationControversies in the management of early endometrial carcinoma: an update
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Reddi PR et al. Int J Reprod Contracept Obstet Gynecol. 2017 Jun;6(6):2124-2131 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172301
More informationUPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER
UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER Susan Davidson, MD Professor Department of Obstetrics and Gynecology Division of Gynecologic Oncology University of Colorado- Denver Anatomy Review
More informationGynecologic Cancer InterGroup Cervix Cancer Research Network. Management of Cervical Cancer in Resource Limited Settings.
Management of Cervical Cancer in Resource Limited Settings Linus Chuang MD Conflict of Interests None Cervical cancer is the fourth most common malignancy in women worldwide 530,000 new cases per year
More informationFactors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage
Factors predictive of myoinvasion in cases of Complex Atypical Hyperplasia diagnosed on endometrial biopsy or curettage Jessica Johns, MD Jeffrey Killeen, MD Robert Kim, MD Hyeong Jun Ahn, PhD None Disclosures
More informationGERM CELL OVARIAN TUMORS: AN ITALIAN EXPERIENCE
I.R.C.C.S SAN RAFFAELE HOSPITAL-MILAN GERM CELL OVARIAN TUMORS: AN ITALIAN EXPERIENCE Dott.ssa Giorgia Mangili Gynecology and Obstetric Department, IRCCS San Raffaele Hospital Milan. 11/06/2010 PATIENTS
More informationGCIG Rare Tumour Brainstorming Day
GCIG Rare Tumour Brainstorming Day Relatively (Not So) Rare Tumours Adenocarcinoma of Cervix Keiichi Fujiwara, Ros Glasspool Benedicte Votan, Jim Paul Aim of the Day To develop at least one clinical trial
More informationLocally advanced disease & challenges in management
Gynecologic Cancer InterGroup Cervix Cancer Research Network Cervix Cancer Education Symposium, February 2018 Locally advanced disease & challenges in management Carien Creutzberg Radiation Oncology, Leiden
More informationEndometrial Cancer. Incidence. Types 3/25/2019
Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy
More informationProf. Dr. Aydın ÖZSARAN
Prof. Dr. Aydın ÖZSARAN Adenocarcinomas of the endometrium Most common gynecologic malignancy in developed countries Second most common in developing countries. Adenocarcinomas, grade 1 and 2 endometrioid
More information2. Material and Methods. 3. Statistical Methods. 4. Results. 2 ISRN Oncology
International Scholarly Research Network ISRN Oncology Volume 2012, Article ID 178051, 10 pages doi:10.5402/2012/178051 Clinical Study Treatment Outcomes and Prognostic Factors in Mexican Patients with
More informationGCIG Cervix Committee: Chicago, USA May 30th Satoru Sagae (JGOG) Bradley Monk (GOG)
GCIG Cervix Committee: Chicago, USA May 30th 2013 Satoru Sagae (JGOG) Bradley Monk (GOG) Conflict of Interest Disclosures CURRENT ACTIVE/NEAR ACTIVATION RANDOMIZED TRIALS WITH GCIG PARTICIPATION: Wellcome
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationAdjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
Original paper Clinical Investigations Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer Harriet Belding Eldredge-Hindy, MD 1, Gary Eastwick, BS 1, Pramila Rani Anne, MD
More informationCase presentation 04/13/2017. Genomic/morphological classification of endometrial carcinoma
Genomic/morphological classification of endometrial carcinoma Robert A. Soslow, MD soslowr@mskcc.org architecture.about.com Case presentation 49 year old woman with vaginal bleeding Underwent endometrial
More informationArticles. Copyright The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC-BY-NC-ND 4.0 license.
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial Stephanie
More informationNeoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy
Case Report Obstet Gynecol Sci 2014;57(6):539-543 http://dx.doi.org/10.5468/ogs.2014.57.6.539 pissn 2287-8572 eissn 2287-8580 Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for
More informationThe clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population
Zhang et al. BMC Cancer (2019) 19:22 https://doi.org/10.1186/s12885-018-5147-2 RESEARCH ARTICLE Open Access The clinicopathological features and treatment modalities associated with survival of neuroendocrine
More informationSAMO MASTERCLASS Bern, Prof. C. Sessa IOSI - Bellinzona
SAMO MASTERCLASS Bern, 13.09.2014 Gynecological cancers Prof. C. Sessa IOSI - Bellinzona Epithelial ovarian cancer Epidemiology Fourth most common cause of female mortality Incidence 13/100 000 woman/yr
More informationPre-operative Evaluation and Implications
Pre-operative Evaluation and Implications Michal Zikan Gynecologic Oncology Center Charles University in Prague, First Faculty of Medicine No recommendation for screening of EC (HNPCC annual biopsies starting
More informationHemoglobin A1c and the relationship to stage and grade of endometrial cancer
DOI 10.1007/s00404-012-2455-7 GYNECOLOGIC ONCOLOGY Hemoglobin A1c and the relationship to stage and grade of endometrial cancer Erin E. Stevens Sarah Yu Melanie Van Sise Tana Shah Pradhan Vanessa Lee Michael
More information2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA
2009 USCAP Gyn Pathology Evening Session Case #3 Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA rzaino@psu.edu Clinical history Middle aged woman with an exophytic mass of
More informationCervixcancer. Vad är aktuellt? Jan Persson. Lund. Docent överläkare Dep of OB&G Skane univ hosp Lund Sweden
Cervixcancer Copyright Jan Persson Lund Vad är aktuellt? Jan Persson Docent överläkare Dep of OB&G Skane univ hosp Lund Sweden Controversies Preop selection related stage ( stage 1b1>= 2 cm) Neoadjuvant
More informationJanjira Petsuksiri, M.D
GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors
More informationInvasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous
Note: If available, clinical trials should be considered as preferred treatment options for eligible patients (www.mdanderson.org/gynonctrials). Other co-morbidities are taken into consideration prior
More informationLaparoscopic Management of Early Stage Endometrial Cancer. B. Rabischong, M. Canis, G. Le Bouedec, C. Pomel, J.L Achard, J. Dauplat, G.
Laparoscopic Management of Early Stage Endometrial Cancer B. Rabischong, M. Canis, G. Le Bouedec, C. Pomel, J.L Achard, J. Dauplat, G. Mage Early Stage of Endometrial Cancer most of cases diagnosed (clinical
More informationJJCO. Original Article. Banghyun Lee 1, Dong Hoon Suh 2, Kidong Kim 2, Jae Hong No 2, and Yong Beom Kim 2,3, * Abstract
JJCO Japanese Journal of Clinical Oncology Japanese Journal of Clinical Oncology, 2016, 46(8) 711 717 doi: 10.1093/jjco/hyw063 Advance Access Publication Date: 20 May 2016 Original Article Original Article
More informationPrognostic significance of positive lymph node number in early cervical cancer
1052 Prognostic significance of positive lymph node number in early cervical cancer JUNG WOO PARK and JONG WOON BAE Department of Obstetrics and Gynecology, Dong A University Hospital, Dong A University
More informationIs Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?
Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer? Lee H, Park JY, Youn S, Kwon W, Heo JS, Choi SH, Choi DW Department of Surgery, Samsung Medical Center Sungkyunkwan
More informationImpact of body mass index on the prognosis of Korean women with endometrioid adenocarcinoma of the uterus: A cohort study
Original Article Obstet Gynecol Sci 2014;57(2):115-120 http://dx.doi.org/10.5468/ogs.2014.57.2.115 pissn 2287-8572 eissn 2287-8580 Impact of body mass index on the prognosis of Korean women with endometrioid
More informationTherapeutic Role of Lymph Node Resection in Endometrioid Corpus Cancer. BACKGROUND. The purpose of the current study was to determine the potential
1823 Therapeutic Role of Lymph Node Resection in Endometrioid Corpus Cancer A Study of 12,333 Patients John K. Chan, MD 1 Michael K. Cheung, BA 1 Warner K. Huh, MD 3 Kathryn Osann, PhD 4 Amreen Husain,
More informationStage IVB endometrial cancer confined to the abdomen: is chemotherapy superior to radiotherapy?
European Journal of EJGO Gynaecological Oncology Stage IVB endometrial cancer confined to the abdomen: is chemotherapy superior to radiotherapy? D. Akdag Cirik, A. Karalok, I. Ureyen, T. Tasci, S. Koc,
More informationMRI for cervical and endometrial cancers. Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB
MRI for cervical and endometrial cancers Dr Robert Bleehen Consultant Radiologist Cardiff & Vale UHB RCR 06(1) RCR 06(1) Technique Pelvic multiphased-array coil Fasting? Buscopan? ABDOMEN!!! Cx:+/- HR
More informationAnalysis of Prognosis and Prognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix
DOI 10.1007/s11805-009-0133-8 133 Analysis of rognosis and rognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix Guangwen Yuan Lingying Wu Xiaoguang Li Manni Huang Department
More informationCytological Features of Cervical Smears in Serous Adenocarcinoma of the Endometrium
Jpn J Clin Oncol 2003;33(12)636 641 Cytological Features of Cervical Smears in Serous Adenocarcinoma of the Endometrium Yukiharu Todo, Shinichirou Minobe, Kazuhira Okamoto, Mahito Takeda, Yasuhiko Ebina,
More informationPatterns of care and the survival of elderly patients with high-risk endometrial cancer: A case-control study from the FRANCOGYN group
Patterns of care and the survival of elderly patients with high-risk endometrial cancer: A case-control study from the FRANCOGYN group Aline Rousselin, Sofiane Bendifallah, Krystel Nyangoh Timoh, Lobna
More informationUpdate on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact
Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most
More informationReview Article Controversies in the Treatment of Early Stage Endometrial Carcinoma
Obstetrics and Gynecology International Volume 2012, Article ID 578490, 8 pages doi:10.1155/2012/578490 Review Article Controversies in the Treatment of Early Stage Endometrial Carcinoma Joshua Z. Press
More informationUterus Malignancies /5/15
Collecting Cancer Data: Uterus 2014-2015 NAACCR Webinar Series February 5, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching
More informationOutcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix
British Journal of Cancer (2010) 102, 1692 1698 All rights reserved 0007 0920/10 www.bjcancer.com Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix J-Y Park
More informationNewton Wellesley Hospital 2013
Newton Wellesley Hospital 20 Standard 4.6 Assessment and Evaluation of Treatment Planning Endometrial Cancer Each year a physician member of the cancer committee conducts a study to ensure that diagnostic
More informationDoes Lower Uterine Segment Involvement in Grade 3 Endometrial Cancer Impact Recurrence Patterns and Patient Outcomes?
Elmer Press Original Article Does Lower Uterine Segment Involvement in Grade 3 Endometrial Cancer Impact Recurrence Patterns and Patient Outcomes? Leslie H. Clark a, b, d, Paola A. Gehrig a, b, Victoria
More informationECC or Margins Positive?
CLINICAL PRESENTATION This practice algorithm has been specifically developed for M. D. Anderson using a multidisciplinary approach and taking into consideration circumstances particular to M. D. Anderson,
More informationThe Role of Radiotherapy in Endometrial Cancer: Current Evidence and Trends
Curr Oncol Rep (2011) 13:472 478 DOI 10.1007/s11912-011-0191-y GYNECOLOGIC CANCERS (JONATHAN A. LEDERMANN, SECTION EDITOR) The Role of Radiotherapy in Endometrial Cancer: Current Evidence and Trends Carien
More informationTOC NCCN Categories of Evidence and Consensus Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2A: Based upon lower-level evidence,
More informationMOLECULAR AND CLINICAL ONCOLOGY 5: , 2016
MOLECULAR AND CLINICAL ONCOLOGY 5: 467-474, 2016 Prognostic impact of primary tumor SUV max on preoperative 18 F fluoro 2 deoxy D glucose positron emission tomography and computed tomography in endometrial
More informationStudy Title The SACS trial - Phase II Study of Adjuvant Therapy in CarcinoSarcoma of the Uterus
Study Title The SACS trial - Phase II Study of Adjuvant Therapy in CarcinoSarcoma of the Uterus Investigators Dr Bronwyn King, Peter MacCallum Cancer Centre Dr Linda Mileshkin, Peter MacCallum Cancer Centre
More informationCancer of the corpus uteri
DOI: 10.1002/ijgo.12612 FIGO CANCER REPORT 2018 Cancer of the corpus uteri Frédéric Amant 1,2,3, * Mansoor Raza Mirza 4 Martin Koskas 5 Carien L. Creutzberg 6 1 Division of Gynecologic Oncology, University
More information